ANDA 74849, held by Teva. Clomipramine Hydrochloride.
As of Nov 16, 2026, ANDA 74849 (Clomipramine Hydrochloride), held by Teva, was first approved by FDA on Apr 4, 1997, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 4, 1997 | Original application | Approved | None posted |
| Clomipramine Hydrochloride25MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride50MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride75MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Jan 20, 2000 | Supplement 6Labeling | Approved | None posted |
| Aug 24, 1999 | Supplement 4Labeling | Approved | None posted |
| Feb 4, 1999 | Supplement 3Labeling | Approved | None posted |
| May 15, 1998 | Supplement 2Labeling | Approved | None posted |
| Apr 4, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters